Artemisinin Exerts Antifungal Activity Against Candida glabrata via Transcriptional Mediator MED15 by Modulating Lipid Biosynthesis and Biofilm Formation
Fungal infections represent a significant threat to human health, yet available antifungal agents are limited, thereby underscoring the urgent need for the development of novel therapeutic strategies. Although artemisinin has demonstrated potential antifungal properties, the precise mechanisms underlying its activity have yet to be fully elucidated. Here, we identified the transcriptional mediator MED15 as a key regulator of artemisinin’s antifungal effects through the application of drug sensitivity assays. Further, transcriptomic analyses were employed to characterize the transcriptional regulatory role of MED15 in mediating artemisinin’s antifungal activity, focusing on lipid and ergosterol biosynthetic pathways. Moreover, the regulatory function of MED15 was validated in the pathogenic fungus Candida glabrata. Our findings indicate that MED15 modulates lipid-ergosterol biosynthesis-related genes, which consequently affects biofilm development and fungal susceptibility to artemisinin. This work provides new mechanistic insights into artemisinin-mediated antifungal effects and offers a theoretical basis for developing antifungal therapeutic strategies.
Authors
- Yining Sun (ORCID: https://orcid.org/0009-0004-7806-4992)
- Pan Zhu (ORCID: https://orcid.org/0009-0008-2576-5970)
- Xiulai Chen (ORCID: https://orcid.org/0000-0002-9749-4558)
- Liang Guo
- Zihan Yuan
- Maomin Ran
- Shezi Du
Institutions
- Jiangnan University (CN)
- Shanxi Normal University (CN)
Publication Details
- Journal
- International Journal of Molecular Sciences
- Published
- 2026-11-18
- DOI
- https://doi.org/10.3390/ijms272210338
- Primary Topic
- Antifungal resistance and susceptibility
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Natural Science Foundation of Shanxi Province
- Fundamental Research Funds for the Central Universities